LeMaitre price target lowered to $24 from $30 at Lake Street

Lake Street analyst Brooks O’Neil lowered his price target for LeMaitre Vascular to $24 and maintains a Hold rating on the shares. Toward the end of 2018, LeMaitre backed away from its long-term guidance for 10% revenue growth and 20% earnings growth, O’Neil tells investors in a research note.
https://thefly.com/landingPageNews.php?id=2852373